Intrinsic Edge Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
OAM
HRCM
FAM
GS
Intrinsic Edge Capital Management's CDNA Position: Q1 2025 in Review
Intrinsic Edge Capital Management sold out of CareDx (CDNA) in Q1 2025, closing a stake of 255,000 shares — an estimated $5.46M sold.
Intrinsic Edge Capital Management first reported a position in CDNA in Q1 2019 and held it in 14 quarters. The position peaked at $18.9M in Q2 2019. 218 funds tracked by Wall St. Rank hold CDNA as of Q1 2025.
- Intrinsic Edge Capital Management reported no remaining CareDx position as of Q1 2025 after selling out during the quarter.
- Intrinsic Edge Capital Management sold 255,000 CareDx shares in Q1 2025, an estimated $5.46M.
- Intrinsic Edge Capital Management first reported a position in CareDx in Q1 2019 and held it in 14 quarters.
- Intrinsic Edge Capital Management's CareDx position peaked at $18.9M in Q2 2019.
- 218 funds tracked by Wall St. Rank held CareDx as of Q1 2025.
Based on Intrinsic Edge Capital Management's 13F filing for Q1 2025, filed 12 May 2025.